OtherNeuropharmacology
Pharmacological Properties of ABT-239: II. Neurophysiological Characterization and Broad Preclinical Efficacy in Cognition and Schizophrenia of a Potent and Selective Histamine H3 Receptor Antagonist
Gerard B. Fox, Timothy A. Esbenshade, Jia Bao Pan, Richard J. Radek, Kathleen M. Krueger, Betty B. Yao, Kaitlin E. Browman, Michael J. Buckley, Michael E. Ballard, Victoria A. Komater, Holly Miner, Min Zhang, Ramin Faghih, Lynne E. Rueter, Robert S. Bitner, Karla U. Drescher, Jill Wetter, Kennan Marsh, Martine Lemaire, Roger D. Porsolt, Youssef L. Bennani, James P. Sullivan, Marlon D. Cowart, Michael W. Decker and Arthur A. Hancock
Journal of Pharmacology and Experimental Therapeutics December 17, 2004, DOI: https://doi.org/10.1124/jpet.104.078402
Gerard B. Fox
Timothy A. Esbenshade
Jia Bao Pan
Richard J. Radek
Kathleen M. Krueger
Betty B. Yao
Kaitlin E. Browman
Michael J. Buckley
Michael E. Ballard
Victoria A. Komater
Holly Miner
Min Zhang
Ramin Faghih
Lynne E. Rueter
Robert S. Bitner
Karla U. Drescher
Jill Wetter
Kennan Marsh
Martine Lemaire
Roger D. Porsolt
Youssef L. Bennani
James P. Sullivan
Marlon D. Cowart
Michael W. Decker

This is a PDF-only article. The first page of the PDF of this article appears below.

In this issue
OtherNeuropharmacology
Pharmacological Properties of ABT-239: II. Neurophysiological Characterization and Broad Preclinical Efficacy in Cognition and Schizophrenia of a Potent and Selective Histamine H3 Receptor Antagonist
Gerard B. Fox, Timothy A. Esbenshade, Jia Bao Pan, Richard J. Radek, Kathleen M. Krueger, Betty B. Yao, Kaitlin E. Browman, Michael J. Buckley, Michael E. Ballard, Victoria A. Komater, Holly Miner, Min Zhang, Ramin Faghih, Lynne E. Rueter, Robert S. Bitner, Karla U. Drescher, Jill Wetter, Kennan Marsh, Martine Lemaire, Roger D. Porsolt, Youssef L. Bennani, James P. Sullivan, Marlon D. Cowart, Michael W. Decker and Arthur A. Hancock
Journal of Pharmacology and Experimental Therapeutics December 17, 2004, DOI: https://doi.org/10.1124/jpet.104.078402
OtherNeuropharmacology
Pharmacological Properties of ABT-239: II. Neurophysiological Characterization and Broad Preclinical Efficacy in Cognition and Schizophrenia of a Potent and Selective Histamine H3 Receptor Antagonist
Gerard B. Fox, Timothy A. Esbenshade, Jia Bao Pan, Richard J. Radek, Kathleen M. Krueger, Betty B. Yao, Kaitlin E. Browman, Michael J. Buckley, Michael E. Ballard, Victoria A. Komater, Holly Miner, Min Zhang, Ramin Faghih, Lynne E. Rueter, Robert S. Bitner, Karla U. Drescher, Jill Wetter, Kennan Marsh, Martine Lemaire, Roger D. Porsolt, Youssef L. Bennani, James P. Sullivan, Marlon D. Cowart, Michael W. Decker and Arthur A. Hancock
Journal of Pharmacology and Experimental Therapeutics December 17, 2004, DOI: https://doi.org/10.1124/jpet.104.078402